Significantly enhancing human antibody affinity via deep learning and computational biology-guided single-point mutations
Briefings in Bioinformatics · 2025
DOI: 10.1093/bib/bbaf445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2025. Verfasst von Junxin Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of S…. Hauptthemen laut MEDLINE: Deep Learning, Computational Biology, Antibody Affinity, Point Mutation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Shenzhen Basic Research Fund, National Key R&D Program of China.
Abstract (Originalsprache)
Enhancing antibody affinity is a critical goal in antibody design, as it improves therapeutic efficacy, specificity, and safety while reducing dosage requirements. Traditional methods, such as single-point mutations or combinatorial mutagenesis, are limited by the impracticality of exhaustively exploring the vast mutational space. To address this challenge, we developed a novel computational pipeline that integrates evolutionary constraints, antibody–antigen-specific statistical potentials, molecular dynamics simulations, metadynamics, and a suite of deep learning models to identify affinity-enhancing mutations. Our deep learning framework includes MicroMutate, which predicts microenvironment-specific amino acid mutations, and graph-based models that evaluate postmutation antigen–antibody-binding probabilities. Using this approach, we screened 12 single-point mutant antibodies targeting the hemagglutinin of the H7N9 avian influenza virus, starting from antibodies with initial affinities in the subnanomolar range, with one showing a 4.62-fold improvement. To demonstrate the generalizability of our method, we applied it to engineer an antibody against death receptor 5 with initial affinities in the subnanomolar range, successfully identifying a mutant with a 2.07-fold increase in affinity. Our work underscores the transformative potential of integrating deep learning and computational methods for rapidly and precisely discovering affinity-enhancing mutations while preserving immunogenicity and expression. This approach offers a powerful and universal platform for advancing antibody therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Nanshan District, Shenzhen 518055, China.
- Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Nanshan District, Shenzhen 518055,…
- Faculty of Synthetic Biology, Shenzhen University of Advanced Technology, 1 Beizhen Road, Xinhu Subdistrict, Guangming District, Shenzhen 518055, China.
- Shanghai Frontiers Science Center of Artificial Intelligence and Deep Learning and NYU-ECNU Center for Computational Chemistry, NYU-Shanghai, 1555 Century Avenue, Pudong New Area, Shanghai 200062, China.
- Department of Chemistry, New York University, New York, NY 10003, United States.
- School of Chemistry and Molecular Engineering, East China Normal University, 138 Tongpu Road, Putuo District, Shanghai 200062, China.
ORCID-Profile: John Z H Zhang, Haiping Zhang
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen Basic Research Fund
- National Key R&D Program of China
- National Science Foundation of China
- Shenzhen Key Projects
- Shenzhen Science and Technology Program
- Shenzhen Medical Research Fund
Zitieren
APA
Li, J., Zhang, C., Xia, W., Kan, H. W., Huang, K., Li, S., Ige, M. A., Yu, Q., Zhao, J., Wan, X., Zhang, J. Z. H., & Zhang, H. (2025). Significantly enhancing human antibody affinity via deep learning and computational biology-guided single-point mutations. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbaf445
Vancouver
Li J, Zhang C, Xia W, Kan HW, Huang K, Li S, et al. Significantly enhancing human antibody affinity via deep learning and computational biology-guided single-point mutations. Briefings in Bioinformatics. 2025. doi:10.1093/bib/bbaf445
BibTeX
@article{Li2025,
author = {Li, Junxin and Zhang, Chao and Xia, Wei and Kan, Hei Wun and Huang, Kaifang and Li, Sai and Ige, Mark Akinola and Yu, Qiuliyang and Zhao, Jiawei and Wan, Xiaochun and Zhang, John Z H and Zhang, Haiping},
title = {Significantly enhancing human antibody affinity via deep learning and computational biology-guided single-point mutations},
journal = {Briefings in Bioinformatics},
year = {2025},
doi = {10.1093/bib/bbaf445}
}
EUVIMED